thymopentin has been researched along with Female Genital Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krebs, D; Mallmann, P | 1 |
| Andriani, GC; Beltrandi, E; Ghetti, P; Maldini, M; Negosanti, M | 1 |
2 other study(ies) available for thymopentin and Female Genital Neoplasms
| Article | Year |
|---|---|
[The effect of immunotherapy with thymopentin on the parameters of cellular immunity and the clinical course of gynecologic tumor patients].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Cell Migration Inhibition; Combined Modality Therapy; Female; Genital Neoplasms, Female; Humans; Immunity, Cellular; Immunotherapy; Leukocyte Count; Neoplasm Staging; Ovarian Neoplasms; Peptide Fragments; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thymopentin; Thymopoietins; Thymus Hormones; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
[Thymopentin in the treatment of recurrent condylomata acuminata].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anus Neoplasms; Condylomata Acuminata; Female; Genital Neoplasms, Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Peptide Fragments; Recurrence; Thymopentin; Thymopoietins; Thymus Hormones | 1989 |